Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Spotlight on Executive-in-Residence: Paul Jeffrey

6/22/2015

0 Comments

 
Trenton, NJ - Continuing its commitment to providing resources to emerging New Jersey’s life sciences companies, the New Jersey Economic Development Authority (EDA) has launched its inaugural group of Executives-in-Residence. These highly-qualified life sciences executives mentor and advise emerging technology companies at the Commercialization Center for Innovative Technologies (CCIT), the EDA’s life sciences incubator.  The Executive-in-Residence program was created in collaboration with BioNJ. 
Since starting as CCIT’s inaugural Executive-in-Residence – Valuation and Business Planning, Paul Jeffrey of Ortley Beach has used his talent and broad knowledge of pharmaceutical development and deal making to assist CCIT tenants in maximizing their value to potential partners.  Paul brings a deep understanding of the healthcare industry and more than 30 years of experience at such pharmaceutical giants as Pfizer and Merck to his position. Throughout his career, Paul has led development teams to bring multiple products to market, several of which achieved over $1 billion in total sales. 

During his 27 years at Pfizer, Paul held many roles, including product development, marketing and new business strategy.  In his last position there, he served as Vice President of Early Commercial Development for all prescription products in the Primary Care Business Unit.  He was the Global Marketing Lead for the cardiovascular and metabolic/diabetes products including Lipitor, Caduet and Eliquis.  Paul has led many cross-functional teams across diverse disease areas including infectious disease, HIV, oncology and neuroscience.  His specializations in these subjects have been especially advantageous to tenant companies Aucta Pharmaceuticals and QualComp Consulting Services.

Since leaving Pfizer, Paul has advised several biotechnology companies, including Excaliard and InStar in optimizing their commercialization plan and value to potential partners and investors. He is currently an advisor to Oligomerix, BusStim, and Quantex Labs.

Paul has a Bachelor of Science degree from Carnegie Mellon, a Master of Science degree in organic chemistry from the Massachusetts Institute of Technology, and an MBA from New York University. 

Why did you choose to apply to the Executive-in-Residence program?
I applied to the EIR program because after years of working at a large pharmaceutical company reviewing biotech companies that we might collaborate with or acquire, I realized that this experience would be very helpful in now helping biotechnology companies at CCIT understand how to make themselves more attractive to investors and big pharma.

What do you hope to get out of this Executive-in-Residence program?
By working with the companies at CCIT, I hope to build my experience of working with startup companies and understanding their needs. It will also increase my network among the large NJ biotech network.

What’s the best piece of advice you’ve heard over the years that you hope to impart on these emerging life sciences companies?
"You don't know what you don't know" so you must recognize and accept that and find someone to help you that does know. So often companies fail because they think they know what's needed to be successful, and they fail because they didn't see the pitfall that others would likely have seen ahead of time.

What is the next challenge you want to undertake in your career?
My biggest hope is that some biotechnology companies will recognize that given my vast pharmaceutical experience, I can offer them some very sound advice.  I want to apply my experience in those situations where my advisory services can make a real difference between success and failure for a fledgling company. My tenure at CCIT will hopefully aid in finding some of those companies where I can make a difference.

The EDA is currently accepting applications for its second Executive-in-Residence class.  Optimal for life sciences Executives currently in transition, benefits of the program include networking opportunities with tenants, BioNJ and the greater New Jersey life sciences community; office space at CCIT; the title of Executive-in-Residence; and exposure on EDA’s website.   To learn more about the program or to apply to be an Executive-in-Residence, visit http://www.njeda.com/eir.

For more information about resources available to New Jersey’s life sciences companies, visithttp://www.njeda.com/ccit and follow @NJEDATech on Twitter and LinkedIn.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507